News

VIDEO: Varenicline may help smokers quit gradually


 

FROM JAMA

References

Is it all or nothing when it comes to quitting smoking?

For many smokers, there may be another approach: A new study showed that a 24-week course of varenicline boosted quit rates among smokers who preferred to gradually reduce their cigarette use ( JAMA 2015;313:687-94 ). That behavioral health reduction strategy may offer 14 million smokers an alternative route to quitting, noted study author Dr. Jon O. Ebbert of the Mayo Clinic, Rochester, Minn.

In a video interview, Dr. Ebbert discusses the strategy and its benefits.

Dr. Ebbert reported receiving grants from Pfizer, JHP Pharmaceuticals, and Orexigen, as well as personal fees from GlaxoSmithKline.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

trudd@frontlinemedcom.com

Recommended Reading

FDA panel supports retaining Chantix boxed warning for now
MDedge Psychiatry
Sexsomnia may gain more awareness after DSM-5 inclusion
MDedge Psychiatry
Cigarette smoking rates among U.S. adults hit all-time low
MDedge Psychiatry
Anxiety disorders drive, worsen migraine symptoms
MDedge Psychiatry
Hookah, snus users more likely to start smoking
MDedge Psychiatry
Study ignites concern that e-cigarettes may ‘renormalize’ smoking
MDedge Psychiatry
Cheaper cytisine topped nicotine replacement therapy for smoking cessation
MDedge Psychiatry
Insomnia and e-books
MDedge Psychiatry
Teen screen and electronic use linked to less sleep
MDedge Psychiatry
Varenicline facilitates gradual smoking cessation
MDedge Psychiatry

Related Articles